MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejca.2026.116959

Медицинская библиотека · European journal of cancer (Oxford, England : 1990) · 2026

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

Fox Louis, van Leeuwen Marieke, Jones Jennifer M, Al-Omari Amal, Abaza Haneen, Al-Khaifi Muna, Eichler Martin, Hartup Sue, Velikova Galina, Friðriksdóttir Nanna, Cho Juhee, Vanlaer Nathalie, Rogiers Anne, Costi Stefania, Soncini Silvia, Kjær Trille Kristina, Arndt Volker, Doege Daniela, Alkan Ali, Ishiki Hiroto, Rammant Elke, Baumann Jannike, Sinn Marianne, Annunziata Maria Antonietta, Arraras Juan Ignacio, Van Hemelrijck Mieke, Pace Andrea, Clatworthy Naomi, King Victoria, Tolstrup Lærke Kjær, Shimomura Akihiko, Kontogianni Meropi, Sodergren Samantha C, Vukšić Nikolina, Petersen Morten Aagaard, Kieffer Jacobien M, Jefford Michael, Chalk Tara, Young Teresa, Borda Nayanaben, Morag Ofir, Harle Amelie, Petranović Duška, Meggiolaro Elena, De Padova Silvia, Jansen Femke, Turhal Nazim Serdar, Navarra Chiara Maria, Baumann Ingo, Amdal Cecilie Delphin, Vassiliou Vassilios, Pinto Monica, Kurosawa Saiko, Vistad Ingvild, Al-Balushi Muna, Al-Ghoche Ahmad, Dirven Linda, Capela Andreia, Elsayed Zeinab, Montemuiño Sara, Willisch Patricia, Aaronson Neil, van de Poll-Franse Lonneke, EORTC Quality of Life Group

СтатьяВалидационное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

INTRODUCTION

Cancer survivors face unique and persistent health-related quality of life (HRQoL) challenges. Existing HRQoL questionnaires for survivors lack content regarding chronic physical issues and have typically included limited cancer types and languages/cultures, affecting breadth of content and generalisability. We developed and validated the EORTC QLQ-SURV100, a questionnaire to assess HRQoL in disease-free survivors of diverse cancers. A conceptual framework of HRQoL in cancer survivors, developed in previous study phases and conceptualised as survivors' self-reported physical, mental and social functioning and well-being, formed the basis for questionnaire content.

METHODS

The QLQ-SURV100 was administered to 1480 participants across 46 centres in 21 countries (31% breast cancer, 23% colorectal, 22% prostate, 24% other cancers), who had completed primary treatment 1-10 years earlier and had no evidence of active disease. Structural validity of the 21 multi-item questionnaire scales was assessed via confirmatory factor analysis; test-retest reliability via intraclass correlation coefficients (ICCs); construct validity through known-group comparisons; and cross-cultural validity and sex invariance through differential item functioning (DIF). Item response theory (IRT) analyses evaluated item redundancy and performance.

RESULTS

The QLQ-SURV100 showed strong structural validity (Comparative Fit Index = 0.951; Tucker-Lewis Index = 0.944; Root Mean Square Error of Approximation = 0.046), with most standardised factor loadings > 0.7. Test-retest ICCs exceeded 0.7 for 27 of 35 scales and 0.6 for 34 scales. Known-groups analyses supported most hypotheses, confirming sensitivity to treatment, comorbidity, age, sex, and education. DIF analysis indicated minor cross-cultural item bias, but no sex-related DIF. IRT analysis found no redundant items.

CONCLUSIONS

The EORTC QLQ-SURV100 showed satisfactory structural validity, test-retest reliability and construct validity; limited item redundancy; and measurement invariance across the sex and language groups examined.

Для цитирования: Fox Louis, van Leeuwen Marieke, Jones Jennifer M, Al-Omari Amal, Abaza Haneen, Al-Khaifi Muna, Eichler Martin, Hartup Sue, Velikova Galina, Friðriksdóttir Nanna, Cho Juhee, Vanlaer Nathalie, Rogiers Anne, Costi Stefania, Soncini Silvia, Kjær Trille Kristina, Arndt Volker, Doege Daniela, Alkan Ali, Ishiki Hiroto, Rammant Elke, Baumann Jannike, Sinn Marianne, Annunziata Maria Antonietta, Arraras Juan Ignacio, Van Hemelrijck Mieke, Pace Andrea, Clatworthy Naomi, King Victoria, Tolstrup Lærke Kjær, Shimomura Akihiko, Kontogianni Meropi, Sodergren Samantha C, Vukšić Nikolina, Petersen Morten Aagaard, Kieffer Jacobien M, Jefford Michael, Chalk Tara, Young Teresa, Borda Nayanaben, Morag Ofir, Harle Amelie, Petranović Duška, Meggiolaro Elena, De Padova Silvia, Jansen Femke, Turhal Nazim Serdar, Navarra Chiara Maria, Baumann Ingo, Amdal Cecilie Delphin, Vassiliou Vassilios, Pinto Monica, Kurosawa Saiko, Vistad Ingvild, Al-Balushi Muna, Al-Ghoche Ahmad, Dirven Linda, Capela Andreia, Elsayed Zeinab, Montemuiño Sara, Willisch Patricia, Aaronson Neil, van de Poll-Franse Lonneke, EORTC Quality of Life Group. International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.. European journal of cancer (Oxford, England : 1990). 2026. DOI: 10.1016/j.ejca.2026.116959.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.